| 000 | 01528 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514194722.0 | ||
| 264 | 0 | _c20050131 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a0094-6176 | ||
| 024 | 7 |
_a10.1055/s-2004-831045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaroo, Anjli | |
| 245 | 0 | 0 |
_aBivalirudin in PCI: an overview of the REPLACE-2 trial. _h[electronic resource] |
| 260 |
_bSeminars in thrombosis and hemostasis _cJun 2004 |
||
| 300 |
_a329-36 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 |
_aHirudins _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptide Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aThrombin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLincoff, A Michael | |
| 773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 30 _gno. 3 _gp. 329-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2004-831045 _zAvailable from publisher's website |
| 999 |
_c14984030 _d14984030 |
||